Evidence map›Paper›PMID 24075727›Full record

ArticlePatient education and counseling2013

Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.

Linda Patrick-Miller, Brian L Egleston, Mary Daly, Evelyn Stevens, Dominique Fetzer, Andrea Forman, Lisa Bealin, Christina Rybak, Candace Peterson, Melanie Corbman and 1 more

Abstract read
In one paragraph

Article in Patient education and counseling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Trial
  8. Article
  9. Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Article
  14. Article
  15. Alzheimer's Prevention Initiative Generation Program: Development of anAlzheimer's & dementia (New York, N. Y.) · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Linda Patrick-MillerDepartment of Medicine, Division of Hematology-Oncology, The University of Chicago, Chicago, USA; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, USA.
Brian L Egleston
Mary Daly
Evelyn Stevens
Dominique Fetzer
Andrea Forman
Lisa Bealin
Christina Rybak
Candace Peterson
Melanie Corbman
Angela R Bradbury

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
Returning genetic research panel results for breast cancer susceptibilityR01CA190871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2014 to 2025
$6.7M
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family RegistryR01CA138819 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI BRADBURY, ANGELA R., DALY, MARY BERYL · 2011 to 2015
$3.3M
Communicating Genetic Test Results by Telephone: A Randomized TrialR01CA160847 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2012 to 2015
$2.5M
Lincoln University-Fox Chase Partnership in Cancer Research and Training (2 of 2)P20CA138017 · NCI · FOX CHASE CANCER CENTER · PI BECK, JOHN ROBERT, CHIKWEM, JOHN O · 2008 to 2011
$1.6M
Lincoln University-Fox Chase Partnership in Cancer Research and Training 1 of 2P20CA138068 · NCI · LINCOLN UNIVERSITY · PI BECK, JOHN ROBERT, HULL, ANNA KAROLINA · 2008 to 2011
$544k
NCI NIH HHS 3P20CA138017-01S1NCI NIH HHS K12 CA139160NCI NIH HHS L30 CA130130NCI NIH HHS P20 CA138017NCI NIH HHS P20 CA138068NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA138819NCI NIH HHS R01 CA160847NCI NIH HHS R01 CA190871
6 · The paper itself

Abstract

objectivesWith an increasing demand for genetic services, effective and efficient delivery models for genetic testing are needed.

methodsIn this prospective single-arm communication study, participants received clinical BRCA1/2 results by telephone with a genetic counselor and completed surveys at baseline, after telephone disclosure (TD) and after in-person clinical follow-up.

resultsSixty percent of women agreed to participate; 73% of decliners preferred in-person communication. Anxiety decreased from baseline to post-TD (p=0.03) and satisfaction increased (p<0.01). Knowledge did not change significantly from baseline to post-TD, but was higher post-clinical follow-up (p=0.04). Cancer patients had greater declines in state anxiety and African-American participants reported less increase in satisfaction. 28% of participants did not return for in-person clinical follow-up, particularly those with less formal education, and higher post-disclosure anxiety and depression (p<0.01).

conclusionsTelephone disclosure of BRCA1/2 test results may not be associated with negative cognitive and affective responses among willing patients, although some subgroups may experience less favorable responses. Some patients do not return for in-person clinical follow-up and longitudinal outcomes are unknown. PRACTICE IMPLICATIONS: Further evaluation of longitudinal outcomes of telephone disclosure and differences among subgroups can inform how to best incorporate telephone communication into delivery of genetic services.

Indexed as

CommunicationDisclosureGenes, BRCA1Genes, BRCA2Genetic TestingTelephoneAdultAgedAnxietyBreast NeoplasmsDepressionFeasibility StudiesFemaleGenetic CounselingGenetic Predisposition to DiseaseHumansCancer risk assessmentCancer susceptibilityCommunicationGenetic testing

Identifiers

PMID24075727
PMCPMC4199583

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.